Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Clinical trial program for anticancer HER-2/neu inhibitor

Oct. 11, 1996

SuperGen acquires rights to Warner-Lambert anticancer drug

Oct. 11, 1996

Kanebo reports antitumor agent with a novel mechanism of action

Oct. 11, 1996

Japanese researchers report new antimetastatic agents

Oct. 11, 1996

MMP inhibitors from Otsuka

Oct. 11, 1996

DuPont Merck describes bisnaphthalimide anticancer drugs

Oct. 11, 1996

ProScript licenses rights to inhibitors of Ras processing

Oct. 11, 1996

Merck describes natural inhibitors of Ras farnesylation

Oct. 11, 1996

Farnesyltransferase inhibitors discovered by RPR

Oct. 11, 1996

New company focuses on small molecules that mimic binding regions of Ig proteins

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...